Surgical outcomes of two-stage hepatectomy for colorectal liver metastasis: comparison to a benchmark procedure
- PMID: 30881963
- PMCID: PMC6383016
- DOI: 10.21037/hbsn.2018.12.02
Surgical outcomes of two-stage hepatectomy for colorectal liver metastasis: comparison to a benchmark procedure
Abstract
Background: Two-stage hepatectomy (TSH) with portal vein embolization (PVE) is associated with high morbidity and mortality and may result in liver failure due to insufficient future liver remnant. The objectives of this investigation were to evaluate the short-term outcomes of patients with colorectal cancer liver metastasis who underwent TSH with PVE, and to critically review the selection criteria for TSH-PVE.
Methods: A retrospective review of all patients who were operated due to bi-lobar CRLM during the years 2007-2017 was performed. Patients who underwent TSH-PVE were compared to those who underwent right hepatectomy (RH) only.
Results: Twenty-nine patient underwent TSH, 25 of whom (86.2%) completed both stages. These patients demonstrated a major complication rate of 17%, and a 90-day mortality rate of 3.4%. Most complications (80%) were related to the colonic resection, and one patient developed liver failure. Patients who suffered complications had a trend towards more baseline comorbidities and more liver lesions. Ablative techniques were utilized in 76%. When compared to 35 patients who underwent sole RH, no significant difference was demonstrated in major complication rate (20%) or mortality (0%).
Conclusions: TSH is a relatively safe procedure in selected patients. Ablative techniques can reduce the occurrence of liver insufficiency and should be used liberally when possible. Factors such as number of lesions, comorbidities and the timing of colonic resection should be considered and evaluated in order to improve the outcomes of the procedure.
Keywords: Two-stage hepatectomy (TSH); ablation; bi-lobar; colorectal liver metastasis; patient selection.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures
Comment in
-
Refining the surgical playbook for treating colorectal cancer liver metastases.Hepatobiliary Surg Nutr. 2021 Jun;10(3):397-400. doi: 10.21037/hbsn-21-31. Hepatobiliary Surg Nutr. 2021. PMID: 34159174 Free PMC article. No abstract available.
-
Editorial comment on: surgical outcomes of two-stage hepatectomy for colorectal liver metastasis: comparison to a benchmark procedure.Hepatobiliary Surg Nutr. 2021 Aug;10(4):570-572. doi: 10.21037/hbsn-21-166. Hepatobiliary Surg Nutr. 2021. PMID: 34430547 Free PMC article. No abstract available.
Similar articles
-
Conventional Two-Stage Hepatectomy or Associating Liver Partitioning and Portal Vein Ligation for Staged Hepatectomy for Colorectal Liver Metastases? A Systematic Review and Meta-Analysis.Front Oncol. 2020 Aug 21;10:1391. doi: 10.3389/fonc.2020.01391. eCollection 2020. Front Oncol. 2020. PMID: 32974141 Free PMC article.
-
ALPPS versus two-stage hepatectomy for colorectal liver metastases--a comparative retrospective cohort study.World J Surg Oncol. 2020 Jun 24;18(1):140. doi: 10.1186/s12957-020-01919-3. World J Surg Oncol. 2020. PMID: 32580729 Free PMC article.
-
Fast-track two-stage hepatectomy by concurrent portal vein embolization at first-stage hepatectomy in hybrid interventional radiology / operating suite.Surg Oncol. 2021 Dec;39:101648. doi: 10.1016/j.suronc.2021.101648. Epub 2021 Aug 16. Surg Oncol. 2021. PMID: 34438236
-
Preoperative portal vein embolization for major liver resection: a meta-analysis.Ann Surg. 2008 Jan;247(1):49-57. doi: 10.1097/SLA.0b013e31815f6e5b. Ann Surg. 2008. PMID: 18156923
-
Methods to Increase Future Liver Remnant Volume in Patients with Primarily Unresectable Colorectal Liver Metastases: Current State and Future Perspectives.Anticancer Res. 2016 May;36(5):2065-71. Anticancer Res. 2016. PMID: 27127106 Review.
Cited by
-
Evaluation of two-stage hepatectomy using portal vein embolization for colorectal liver metastasis: a retrospective nationwide cohort survey in Japan.Int J Surg. 2024 Oct 1;110(10):6691-6701. doi: 10.1097/JS9.0000000000001811. Int J Surg. 2024. PMID: 38869986 Free PMC article.
-
Is interval chemotherapy safe and does it improve the outcome of patients with colorectal liver metastases undergoing multimodal two-stage hepatectomy? - A systematic literature review.BMC Cancer. 2024 Oct 10;24(1):1260. doi: 10.1186/s12885-024-13008-9. BMC Cancer. 2024. PMID: 39390396 Free PMC article.
-
Multiple liver metastases of pulmonary carcinoid successfully treated by two-stage hepatectomy combined with embolization of portal vein branches: Report of a case.Int J Surg Case Rep. 2020;71:319-322. doi: 10.1016/j.ijscr.2020.05.043. Epub 2020 May 29. Int J Surg Case Rep. 2020. PMID: 32492643 Free PMC article.
-
Refining the surgical playbook for treating colorectal cancer liver metastases.Hepatobiliary Surg Nutr. 2021 Jun;10(3):397-400. doi: 10.21037/hbsn-21-31. Hepatobiliary Surg Nutr. 2021. PMID: 34159174 Free PMC article. No abstract available.
-
Conventional Two-Stage Hepatectomy or Associating Liver Partitioning and Portal Vein Ligation for Staged Hepatectomy for Colorectal Liver Metastases? A Systematic Review and Meta-Analysis.Front Oncol. 2020 Aug 21;10:1391. doi: 10.3389/fonc.2020.01391. eCollection 2020. Front Oncol. 2020. PMID: 32974141 Free PMC article.
References
-
- Global Burden of Disease Cancer Collaboration , Fitzmaurice C, Akinyemiju TF, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol 2018;4:1553-68. 10.1001/jamaoncol.2018.2706 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources